Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant hyperthermia.

Syed Z Ali1, Akiko Taguchi, Henry Rosenberg

  • 1Department of Anaesthesiology, University of Berne, Inselspital, 3010 Berne, Switzerland.

Best Practice & Research. Clinical Anaesthesiology
|December 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adequacy Criteria for Thyroid Fine-Needle Aspiration in the Era of the Bethesda Reporting System.

Yonsei medical journal·2026
Same author

Cytopathology of Sister Mary Joseph nodules: the Johns Hopkins experience.

Journal of the American Society of Cytopathology·2026
Same author

TP53/KRAS variant allele frequency ratio predicts advanced disease in mucin-producing cystic neoplasms of the pancreas.

American journal of clinical pathology·2025
Same author

Cytopathologic and histopathologic characteristics of SMARCB1 deficient neoplasm and correlation with molecular and immunohistochemical findings.

Human pathology·2025
Same author

Impact of thyroid Bethesda category IV (follicular neoplasm) terminology unification on atypia of undetermined significance reporting patterns in thyroid fine-needle aspiration.

Journal of the American Society of Cytopathology·2025
Same author

Volatile Anesthetic Intensive Care Unit Sedation: Comment.

Anesthesiology·2025
Same journal

Reimagining cardiac surgery-the emerging role of prehabilitation and risk optimization.

Best practice & research. Clinical anaesthesiology·2026
Same journal

Prehabilitation and enhanced recovery after cardiac surgery.

Best practice & research. Clinical anaesthesiology·2026
Same journal

The role of biomarkers in the preoperative evaluation of cardiac surgical patients - A narrative review.

Best practice & research. Clinical anaesthesiology·2026
Same journal

Magic in a bottle? A Focused review of factor concentrates for the intraoperative treatment of acquired coagulopathy - Fibrinogen concentrate, prothrombin complex concentrate, and recombinant activated factor VII.

Best practice & research. Clinical anaesthesiology·2025
Same journal

ESAs in perioperative anemia management: Who, what, how and why?

Best practice & research. Clinical anaesthesiology·2025
Same journal

Does patient blood management represent good value for money?

Best practice & research. Clinical anaesthesiology·2025
See all related articles

Malignant hyperthermia (MH) is a rare, life-threatening muscle disorder triggered by anesthesia. Prompt treatment with dantrolene and supportive care significantly reduces mortality from this condition.

Area of Science:

  • Pharmacogenetics
  • Muscle Physiology
  • Anesthesiology

Background:

  • Malignant hyperthermia (MH) is a rare, acute, life-threatening pharmacogenetic disorder affecting skeletal muscle.
  • It is triggered by specific anesthetic agents and muscle relaxants in susceptible individuals.
  • MH shares potential links with heat stroke and exercise-induced rhabdomyolysis.

Purpose of the Study:

  • To provide an overview and update on malignant hyperthermia.
  • To discuss the pathophysiology, clinical presentation, and genetic basis of MH.
  • To highlight current treatment strategies and outcomes.

Main Methods:

  • Review of clinical and research investigations on malignant hyperthermia.
  • Analysis of the pathophysiology involving calcium release from the sarcoplasmic reticulum.

Related Experiment Videos

  • Examination of genetic mutations, particularly in the ryanodine receptor gene.

    • Main Results:

    • MH crisis involves uncontrolled calcium release, leading to hypermetabolism, acidosis, and potential organ failure.
    • Classical symptoms include rising end-tidal carbon dioxide, rigidity, tachycardia, hyperthermia, and acidosis.
    • Mortality has decreased from 70% to under 5% due to early recognition, education, and dantrolene treatment.

    Conclusions:

    • Malignant hyperthermia is a serious condition primarily linked to mutations in the ryanodine receptor gene.
    • Early recognition and prompt treatment, including dantrolene administration, are critical for survival.
    • Ongoing research and education have significantly improved outcomes for MH patients.